135 related articles for article (PubMed ID: 31983622)
1. HER2 Status in Molecular Subtypes of Urothelial Carcinoma of the Renal Pelvis and Ureter.
Yorozu T; Sato S; Kimura T; Iwatani K; Onuma H; Yanagisawa T; Miki J; Egawa S; Ikegami M; Takahashi H
Clin Genitourin Cancer; 2020 Aug; 18(4):e443-e449. PubMed ID: 31983622
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and Immunohistochemical Study of Combined Small Cell Carcinoma and Urothelial Carcinoma Molecular Subtype.
Xiao GQ; Barrett MM; Yang Q; Unger PD
Pathol Oncol Res; 2019 Jul; 25(3):889-895. PubMed ID: 29249035
[TBL] [Abstract][Full Text] [Related]
3. Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters.
Ehsani L; Osunkoya AO
Int J Clin Exp Pathol; 2014; 7(5):2544-50. PubMed ID: 24966967
[TBL] [Abstract][Full Text] [Related]
4. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
[TBL] [Abstract][Full Text] [Related]
5. [The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival].
Fontana LO; García García F; Arcas Martínez Salas I; García Ligero J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Canteras Jordana M
Arch Esp Urol; 2002 Sep; 55(7):792-6. PubMed ID: 12380307
[TBL] [Abstract][Full Text] [Related]
6. HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas.
Aumayr K; Klatte T; Neudert B; Birner P; Shariat S; Schmidinger M; Susani M; Haitel A
Pathol Oncol Res; 2018 Jul; 24(3):575-581. PubMed ID: 28755093
[TBL] [Abstract][Full Text] [Related]
7. The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.
Shyr CR; Chen CC; Hsieh TF; Chang CH; Ma WL; Yeh S; Messing E; Li TH; Li FY; Chang C
Endocrine; 2013 Feb; 43(1):191-9. PubMed ID: 22851332
[TBL] [Abstract][Full Text] [Related]
8. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
Zinnall U; Weyerer V; Compérat E; Camparo P; Gaisa NT; Knuechel-Clarke R; Perren A; Lugli A; Toma M; Baretton G; Kristiansen G; Wirtz RM; Cheng L; Wullich B; Stoehr R; Hartmann A; Bertz S
Hum Pathol; 2018 Oct; 80():55-64. PubMed ID: 29885409
[TBL] [Abstract][Full Text] [Related]
9. HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.
Eriksson P; Sjödahl G; Chebil G; Liedberg F; Höglund M
Oncotarget; 2017 Jul; 8(30):48905-48914. PubMed ID: 28388586
[TBL] [Abstract][Full Text] [Related]
10. HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.
Sasaki Y; Sasaki T; Kawai T; Morikawa T; Matsusaka K; Kunita A; Kume H; Aoki I; Homma Y; Fukayama M
Int J Clin Exp Pathol; 2014; 7(2):699-708. PubMed ID: 24551292
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and pathologic characteristics of small cell neuroendocrine carcinoma of urinary tract].
Guo AT; Chen W; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):747-51. PubMed ID: 23302335
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid carcinoma involving the renal pelvis and ureter with heterologous osteosarcomatous differentiation.
Gill-Samra S; Brooks A; P'ng CH
Pathology; 2012 Jun; 44(4):367-9. PubMed ID: 22544213
[No Abstract] [Full Text] [Related]
13. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
[TBL] [Abstract][Full Text] [Related]
14. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
Lwin AA; Hsu CH; Chipollini J
Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
[TBL] [Abstract][Full Text] [Related]
15. Polypoid urothelial tumor with inverted growth pattern in the renal pelvis: morphologic and molecular characteristics of a unique diagnostic entity.
Wobker SE; Zhong M; Epstein JI
Hum Pathol; 2017 Jan; 59():26-33. PubMed ID: 27574810
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
Holmäng S; Lele SM; Johansson SL
J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma.
Fang D; He S; Xiong G; Singla N; Cao Z; Zhang L; Li X; Zhou L
BMC Urol; 2018 Mar; 18(1):22. PubMed ID: 29587736
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the renal pelvis and ureter.
Korkes F; Silveira TS; Castro MG; Cuck G; Fernandes RC; Perez MD
Int Braz J Urol; 2006; 32(6):648-53; discussion 653-5. PubMed ID: 17201942
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
